Michael Szarek

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

Deepak L. Bhatt, Michael Szarek, Philippe Gabríel Steg et al. · New England Journal of Medicine · 2020 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacology +16

HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

Philip J. Barter, Antonio M. Gotto, John C. LaRosa et al. · New England Journal of Medicine · 2007 · 1.6K citations

Medicine, Cardiology, Clinical Epidemiology +9

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

Deepak L. Bhatt, Michael Szarek, Bertram Pitt et al. · New England Journal of Medicine · 2020 · 1.2K citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Vera Bittner, Michael Szarek, Philip E. Aylward et al. · Journal of the American College of Cardiology · 2020 · 572 citations · Full text

Medicine, Cardiology, Pharmacology +17